Predicted protein targets (top 11)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ABCG2 | Q9UNQ0 | 3/20 | 0.53 |
| ▸ | CYP3A4 | P08684 | 2/20 | 0.53 |
| ▸ | MAPK1 | P28482 | 2/20 | 0.53 |
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.53 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.53 |
| ▸ | HPGD | P15428 | 1/20 | 0.53 |
| ▸ | HSD17B10 | Q99714 | 1/20 | 0.53 |
| ▸ | ABCB1 | P08183 | 3/20 | 0.44 |
| ▸ | CYP19A1 | P11511 | 3/20 | 0.44 |
| ▸ | MAOB | P27338 | 1/20 | 0.44 |
| ▸ | AR | P10275 | 1/20 | 0.41 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL6723902 | 0.91 | CYP3A4 (0.55) | ABCG2CYP3A4MAPK1KDM4EALDH1A1 | |
| SCHEMBL5085611 | 0.88 | CYP3A4 (0.49) | CYP3A4MAPK1ALDH1A1HPGDHSD17B10 | |
| SCHEMBL27939651 | 0.88 | CYP3A4 (0.46) | ABCG2CYP3A4MAPK1KDM4EALDH1A1 | |
| SCHEMBL1164995 | 0.86 | ALDH1A1 (0.50) | ABCG2CYP3A4MAPK1KDM4EALDH1A1 | |
| SCHEMBL1164884 | 0.86 | ALDH1A1 (0.50) | ABCG2CYP3A4MAPK1KDM4EALDH1A1 | |
| SCHEMBL5084285 | 0.86 | CYP19A1 (0.44) | ABCG2CYP3A4MAPK1ALDH1A1HPGD | |
| SCHEMBL3364490 | 0.86 | ABCG2 (0.54) | ABCG2CYP3A4MAPK1KDM4EALDH1A1 | |
| SCHEMBL5838277 | 0.84 | PPARG (0.44) | ABCG2CYP3A4MAPK1KDM4EALDH1A1 | |
| SCHEMBL126042 | 0.83 | NR3C1 (0.51) | KDM4EALDH1A1HPGDHSD17B10AR | |
| SCHEMBL10425234 | 0.82 | KDM4E (0.46) | ABCG2CYP3A4MAPK1KDM4EALDH1A1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 29 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| WO-2023219526-A1 | MULTITARGET ANTIVIRAL DIETARY SUPPLEMENT | PROKIN MILAN (RS) | 2023-11-16 | — | — | WO | claimed |
| US-20100098788-A1 | Extracts of Curcuma and Methods of Use Thereof | HERBALSCIENCE GROUP, LLC | 2010-04-22 | — | — | US | claimed |
| WO-2010045577-A2 | EXTRACTS OF CURCUMA AND METHODS OF USE THEREOF | HERBALSCIENCE GROUP, LLC (US) | 2010-04-22 | — | — | WO | claimed |
| CN-119792482-A | Black ginger extract and application thereof in improving bioavailability of berberine hydrochloride sample | 湖南德诺邦尚医药科技有限公司 | 2025-04-11 | — | — | CN | disclosed |
| EP-2484773-A2 | Process for producing anthocyanins | The Research Foundation of State University of New York (US) | 2012-08-08 | — | — | EP | disclosed |
| EP-1784201-B1 | PHYSIOLOGICALLY ACTIVE COMPOSITION AGAINST DIABETES | PHYTOMEDICS INC (US) | 2010-10-20 | — | — | EP | disclosed |
| US-7807422-B2 | set of genes which encodes for enzymes which can convert substrates belonging to the general category of phenylpropanoids and result in the production of flavanones; without the need for chemical conversion | THE RESEARCH FOUNDATION OF STATE UNIVERSITY OF NEW YORK (US) | 2010-10-05 | — | — | US | disclosed |
| US-20100098788-A1 | Extracts of Curcuma and Methods of Use Thereof | HERBALSCIENCE GROUP, LLC | 2010-04-22 | — | — | US | disclosed |
| WO-2010045577-A2 | EXTRACTS OF CURCUMA AND METHODS OF USE THEREOF | HERBALSCIENCE GROUP, LLC (US) | 2010-04-22 | — | — | WO | disclosed |
| US-20090239272-A1 | set of genes which encodes for enzymes which can convert substrates belonging to the general category of phenylpropanoids and result in the production of flavanones; without the need for chemical conversion | KOFFAS MATTHEOS | 2009-09-24 | — | — | US | disclosed |
| CN-100497329-C | Polysubstituted flavanone derivative and its preparation and application | UNIV ZHEJIANG (CN) | 2009-06-10 | — | — | CN | disclosed |
| WO-2006010560-A2 | PHYSIOLOGICALLY ACTIVE COMPOSITION | CARGILL, INCORPORATED (US) | 2006-02-02 | — | — | WO | disclosed |
| US-20060019334-A1 | Introducing the set of genes into a heterologous host cell, allowing growth of the cells in a suitable medium such that the expression of the genes results in production of enzymes; culturing the cell under conditions permitting the synthesis of the flavonoid by the cells; isolating s flavonoids | NATIONAL SCIENCE FOUNDATION | 2006-01-26 | — | — | US | disclosed |
| WO-2006010117-A2 | PRODUCTION OF FLAVONOIDS BY RECOMBINANT MICROORGANISMS | THE RESEARCH FOUNDATION OF STATE UNIVERSITY OF NEW YORK (US) | 2006-01-26 | — | — | WO | disclosed |
| EP-0139614-B1 | PHARMACEUTICAL PREPARATIONS CONTAINING FLAVANONE OR THIOFLAVANONE DERIVATIVES, THE USE THEREOF, NOVEL FLAVANONES AND THIOFLAVANONES, AND PROCESSES FOR THEIR MANUFACTURE | Zyma SA (CH) | 1990-08-22 | — | — | EP | disclosed |
| US-4935441-A | Flavene and thioflavene derivates, processes for their manufacture, pharmaceutical preparations that contain such compounds, and the use of the latter | ZYMA SA (CH) | 1990-06-19 | — | — | US | disclosed |
| US-4885298-A | Pharmaceutical preparations containing flavanone or thioflavanone derivatives the use thereof, novel flavanones and thioflavanones, and processes for their manufacture | ZYMA SA (CH) | 1989-12-05 | — | — | US | disclosed |
| EP-0139615-B1 | FLAVENE AND THIOFLAVENE DERIVATIVES, PROCESSES FOR THEIR MANUFACTURE, PHARMACEUTICAL PREPARATIONS THAT CONTAIN SUCH COMPOUNDS, AND THE USE OF THE LATTER | Zyma SA (CH) | 1989-04-19 | — | — | EP | disclosed |
| EP-0139615-A2 | Flavene and thioflavene derivatives, processes for their manufacture, pharmaceutical preparations that contain such compounds, and the use of the latter | Zyma SA (CH) | 1985-05-02 | — | — | EP | disclosed |
| EP-0139614-A2 | Pharmaceutical preparations containing flavanone or thioflavanone derivatives, the use thereof, novel flavanones and thioflavanones, and processes for their manufacture | Zyma SA (CH) | 1985-05-02 | — | — | EP | disclosed |